T
About
Tempus is a leading AI-powered precision medicine platform designed to transform patient care across oncology, cardiology, neurology, psychiatry, and radiology. At its core, Tempus has assembled the world's largest library of clinical and molecular data, paired with an intelligent operating system that makes that data actionable for healthcare providers, life sciences companies, and patients alike. For providers, Tempus offers genomic profiling, algorithmic diagnostic tests, digital pathology, and EHR integration. Its flagship AI assistant, Tempus ONE, helps clinicians make more informed treatment decisions at the point of care. The NEXT product identifies and closes gaps in care, while LENS provides access to multimodal real-world data (RWD) for research and analytics. ALGOS delivers algorithmic models connected to genomic assays for deeper clinical insight. For life sciences companies, Tempus supports every stage of the drug development pipeline—from early research and biological modeling to clinical trial enrollment, companion diagnostics, and commercialization. Its Tempus Studies and CRO services further streamline clinical trial execution. For patients, Tempus helps match individuals with relevant clinical trials and optimal therapy options based on their unique molecular and clinical profile. Its ECG-AI solution and Tempus Pixel suite extend AI-driven diagnostics into cardiology and radiology imaging. Tempus is built for enterprise healthcare organizations seeking to harness AI for earlier diagnosis, personalized treatment, and accelerated research.
Key Features
- World's Largest Clinical & Molecular Data Library: Tempus has curated an unparalleled repository of clinical and molecular data to power AI models, research, and real-world evidence generation.
- Tempus ONE – AI Assistant for Providers: An AI-enabled assistant that helps healthcare providers make faster, more informed treatment decisions at the point of care.
- LENS – Real-World Data Analytics: A powerful platform for life sciences and research teams to find, access, and analyze multimodal real-world data for drug development and research.
- Genomic Profiling & Algorithmic Tests: Comprehensive tumor sequencing and AI-driven algorithmic models (ALGOS) that provide actionable clinical insights across multiple cancer types.
- Clinical Trial Matching & Enrollment: Automated tools to match patients with relevant clinical trials and assist life sciences companies with enrollment and execution of studies.
Use Cases
- Oncologists using genomic profiling and AI-driven insights to select targeted therapies for cancer patients.
- Pharmaceutical companies leveraging Tempus LENS and real-world data to accelerate clinical development and identify novel drug targets.
- Hospital systems integrating Tempus ONE into EHR workflows to reduce care gaps and improve treatment decision-making.
- Cardiologists deploying ECG-AI and Tempus Pixel Cardio to identify underdiagnosed and undertreated cardiac conditions.
- Research institutions using Tempus's molecular data library and scientific publications to advance precision oncology studies.
Pros
- Comprehensive Multi-Disease Coverage: Tempus spans oncology, cardiology, neurology, psychiatry, and radiology, making it a versatile platform for diverse healthcare organizations.
- Deep EHR & Clinical Workflow Integration: Native EHR integration ensures AI insights are delivered directly within existing clinical workflows, reducing friction for providers.
- End-to-End Life Sciences Support: From early-stage research to companion diagnostics and commercialization, Tempus covers the full pharmaceutical development lifecycle.
- Peer-Reviewed Scientific Credibility: Backed by extensive scientific publications, including Nature Biotechnology studies, demonstrating evidence-based clinical utility.
Cons
- Enterprise-Focused Pricing: Tempus is designed for large healthcare systems and life sciences enterprises, making it inaccessible or cost-prohibitive for smaller clinics or individual practitioners.
- Limited Transparency for End Patients: As a B2B-first platform, individual patients have limited direct access and rely on their providers to leverage Tempus's capabilities.
- Complexity of Platform Adoption: Implementing Tempus across an organization requires significant IT integration work, staff training, and onboarding investment.
Frequently Asked Questions
What diseases does Tempus support?
Tempus primarily focuses on oncology, with robust support for cardiology, neurology, psychiatry, and radiology. Its genomic profiling and AI tools are most mature in the cancer space.
How does Tempus help with clinical trial matching?
Tempus uses its clinical and molecular data library to match patients to relevant clinical trials based on their genomic profile and clinical history, streamlining enrollment for both providers and life sciences sponsors.
What is Tempus ONE?
Tempus ONE is an AI-powered assistant for healthcare providers and researchers that surfaces actionable insights, treatment options, and relevant research at the point of care.
Can pharmaceutical companies use Tempus for drug development?
Yes. Tempus offers life sciences companies access to real-world data (via LENS), biological modeling, companion diagnostics development, CRO services, and clinical trial execution support.
Does Tempus integrate with existing EHR systems?
Yes, Tempus provides EHR integration capabilities so providers can access genomic data, algorithmic insights, and AI-assisted decision support directly within their existing clinical systems.
